Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations? - Response to Adams & Kwee

Br J Haematol. 2018 Apr;181(1):124-125. doi: 10.1111/bjh.14494. Epub 2017 Jan 20.
No abstract available

Keywords: Hodgkin lymphoma; imaging; lymphomas; positron emission tomography; prognostic factors.

Publication types

  • Letter
  • Comment

MeSH terms

  • Child
  • Fluorodeoxyglucose F18*
  • Hodgkin Disease*
  • Humans
  • Positron-Emission Tomography
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18